Authors: Pulkkanen, KJ Parkkinen, JJ Laukkanen, JM Kettunen, MI Tyynela, K Kauppinen, RA Ala-Opas, MY Yla-Herttuala, S

Citation: Kj. Pulkkanen et al., HSV-tk gene therapy for human renal cell carcinoma in nude mice, CANC GENE T, 8(7), 2001, pp. 529-536

Authors: Sandmair, AM Loimas, S Puranen, P Immonen, A Kossila, M Puranen, M Hurskainen, H Tyynela, K Turunen, M Vanninen, R Lehtolainen, P Paljarvi, L Johansson, R Vapalahti, M Yla-Herttuala, S

Citation: Am. Sandmair et al., Thymidine kinase gene therapy for human malignant glioma, using replication-deficient retroviruses or adenoviruses, HUM GENE TH, 11(16), 2000, pp. 2197-2205

Authors: Sandmair, AM Turunen, M Tyynela, K Loimas, S Vainio, P Vanninen, R Vapalahti, M Bjerkvig, R Janne, J Yla-Herttuala, S

Citation: Am. Sandmair et al., Herpes simplex virus thymidine kinase gene therapy in experimental rat BT4C glioma model: Effect of the percentage of thymidine kinase-positive glioma cells on treatment effect, survival time, and tissue reactions, CANC GENE T, 7(3), 2000, pp. 413-421

Authors: Visted, T Thorsen, J Thorsen, F Read, TA Ulvestad, E Engebraaten, O Sorensen, D Yla-Herttuala, S Tyynela, K Rucklidge, G Edvardsen, K Bjerkvig, R Lund-Johansen, M

Citation: T. Visted et al., lacZ-neoR transfected glioma cells in syngeneic rats: Growth pattern and characterization of the host immune response against cells transplanted inside and outside the CNS, INT J CANC, 85(2), 2000, pp. 228-235

Authors: Sandmair, AM Loimas, S Poptani, H Vainio, P Vanninen, R Turunen, M Tyynela, K Vapalahti, M Yla-Herttuala, S

Citation: Am. Sandmair et al., Low efficacy of gene therapy for rat BT4C malignant glioma using intra-tumoural transduction with thymidine kinase retrovirus packaging cell injections and ganciclovir treatment, ACT NEUROCH, 141(8), 1999, pp. 867-872